Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T‐cell acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T‐cell acute lymphoblastic leukaemia

Published:2021-03-25 Issue:6 Volume:193 Page:1096-1104
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Wang Huanping¹²^ORCID,Zhou Yile¹,Huang Xin¹,Zhang Yi¹^ORCID,Qian Jiejing¹,Li Jianhu¹,Li Chenying¹,Li Xueying¹^ORCID,Lou Yinjun¹,Zhu Qiaoyun³,Huang Yujie⁴,Meng Haitao¹,Yu Wenjuan¹,Tong Hongyan¹^ORCID,Jin Jie¹²^ORCID,Zhu Hong‐Hu¹²⁵⁶

Affiliation:

1. Department of Hematology School of Medicine the First Affiliated HospitalZhejiang University HangzhouChina

2. Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment HangzhouChina

3. Central Laboratory School of Medicine the First Affiliated HospitalZhejiang University HangzhouChina

4. Key Laboratory of Drug Clinical Research and Evaluation Technology of Zhejiang Province School of Medicine the First Affiliated HospitalZhejiang University HangzhouChina

5. Zhejiang University Cancer Center HangzhouChina

6. Zhejiang Laboratory for Systems and Precision Medicine Zhejiang University Medical Center Hangzhou China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17424

Reference32 articles.

1. Management of adults with T-cell lymphoblastic leukemia

2. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia

3. Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01